Over 2,000 real rulings β analysed for what they mean to your team. Published every day.
Showing 1914 cases
A clinician complained that AstraZenecaβs public corporate medicines list showed incorrect/missing black triangle symbols and omitted Imjudo. The Panel found a breach…
A GP challenged a Teva-supported insert distributed with Guidelines in Practice. The Panel found it was effectively a paid promotional insert for…
An anonymous GSK employee challenged a diabetes service partnership with a primary healthcare service company. A voicemail and contract implied funding was…
A GP challenged Pfizerβs Toviaz ads comparing fesoterodine 8mg with tolterodine ER. The PMCPA found the comparative claims misleading and unsubstantiated, and…
A nurse alleged she was told Ferinject was safe and could be given as 1,000mg in 15 minutes. The Panel found insufficient…
A GP complained about large promotional emails sent on Sandozβs behalf. The Panel found the email was promotional but could not determine…
A health professional complained about an unsolicited email advertising a Gilead fellowship programme. The Panel found the email was non-promotional and ruled…
Rocheβs Bondronat leavepiece was ruled misleading for indirect cross-trial graphs, exaggerated βrenal safety reassuranceβ claims, and unclear interim poster data. Multiple Clause…
A Lipitor journal ad cited economic modelling (β37%β vs β82%β) on cholesterol target attainment. PMCPA found the bold percentages misleading and not…
Anonymous complaint alleged inappropriate entertainment/hospitality, biased sponsorship of delegates, and suspected off-label selling of Pergoveris at a fertility nurse meeting. PMCPA ruled…
A pharmacist said Sanofi-Aventis didnβt fulfil a reply-paid card request for Acomplia clinical papers and promotional items. Panel and Appeal Board found…
Complaint alleged lunch meetings with no educational content and inflated stand-meeting contacts. Panel found no evidence to support allegations and ruled no…
Anonymous doctor alleged Astellasβ transplant summer school used a lavish venue and linked to aggressive promotion. Panel found hospitality near the limit…
A PCT prescribing advisor challenged a GP email promoting Distaclor MR βstarter packsβ post-flu, citing antimicrobial stewardship and C. difficile risk. Panel…
A prescribing advisor alleged reps advised surgeons to use Pradaxa at an unlicensed βhalf doseβ. The Panel could not determine what transpired…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases β ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week β free.